178 related articles for article (PubMed ID: 20955143)
1. Effect of polyethylene glycols on the trans-ungual delivery of terbinafine.
Nair AB; Chakraborty B; Murthy SN
Curr Drug Deliv; 2010 Dec; 7(5):407-14. PubMed ID: 20955143
[TBL] [Abstract][Full Text] [Related]
2. Trans-ungual iontophoretic delivery of terbinafine.
Nair AB; Vaka SR; Sammeta SM; Kim HD; Friden PM; Chakraborty B; Murthy SN
J Pharm Sci; 2009 May; 98(5):1788-96. PubMed ID: 18781625
[TBL] [Abstract][Full Text] [Related]
3. Alteration of the diffusional barrier property of the nail leads to greater terbinafine drug loading and permeation.
Nair AB; Sammeta SM; Kim HD; Chakraborty B; Friden PM; Murthy SN
Int J Pharm; 2009 Jun; 375(1-2):22-7. PubMed ID: 19481686
[TBL] [Abstract][Full Text] [Related]
4. Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis.
Nair AB; Kim HD; Chakraborty B; Singh J; Zaman M; Gupta A; Friden PM; Murthy SN
J Pharm Sci; 2009 Nov; 98(11):4130-40. PubMed ID: 19340887
[TBL] [Abstract][Full Text] [Related]
5. A study on the effect of inorganic salts in transungual drug delivery of terbinafine.
Nair AB; Sammeta SM; Vaka SR; Narasimha Murthy S
J Pharm Pharmacol; 2009 Apr; 61(4):431-7. PubMed ID: 19298688
[TBL] [Abstract][Full Text] [Related]
6. Transungual delivery of terbinafine by iontophoresis in onychomycotic nails.
Nair AB; Vaka SR; Murthy SN
Drug Dev Ind Pharm; 2011 Oct; 37(10):1253-8. PubMed ID: 21457120
[TBL] [Abstract][Full Text] [Related]
7. Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro.
Vejnovic I; Huonder C; Betz G
Int J Pharm; 2010 Sep; 397(1-2):67-76. PubMed ID: 20620203
[TBL] [Abstract][Full Text] [Related]
8. Two strategies to enhance ungual drug permeation from UV-cured films: Incomplete polymerisation to increase drug release and incorporation of chemical enhancers.
Kerai LV; Bardés J; Hilton S; Murdan S
Eur J Pharm Sci; 2018 Oct; 123():217-227. PubMed ID: 30048800
[TBL] [Abstract][Full Text] [Related]
9. Onychopharmacokinetics of terbinafine hydrochloride penetration from a novel topical formulation into the human nail in vitro.
Hui X; Lindahl Å; Lamel S; Maibach HI
Drug Dev Ind Pharm; 2013 Sep; 39(9):1401-7. PubMed ID: 22873754
[TBL] [Abstract][Full Text] [Related]
10. An ex vivo toe model used to assess applicators for the iontophoretic ungual delivery of terbinafine.
Nair AB; Kim HD; Davis SP; Etheredge R; Barsness M; Friden PM; Murthy SN
Pharm Res; 2009 Sep; 26(9):2194-201. PubMed ID: 19582550
[TBL] [Abstract][Full Text] [Related]
11. Iontophoresis for drug delivery into the nail apparatus: exploring hyponychium as the site of delivery.
Kushwaha A; Shivakumar HN; Murthy SN
Drug Dev Ind Pharm; 2016 Oct; 42(10):1678-82. PubMed ID: 26981643
[TBL] [Abstract][Full Text] [Related]
12. TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.
Murthy SN; Vaka SR; Sammeta SM; Nair AB
J Pharm Sci; 2009 Nov; 98(11):4264-71. PubMed ID: 19363796
[TBL] [Abstract][Full Text] [Related]
13. Trans-ungual Delivery of AR-12, a Novel Antifungal Drug.
Kushwaha AS; Sharma P; Shivakumar HN; Rappleye C; Zukiwski A; Proniuk S; Murthy SN
AAPS PharmSciTech; 2017 Oct; 18(7):2702-2705. PubMed ID: 28289970
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Ungual Permeation of Terbinafine HCl Delivered Through Liposome-Loaded Nail Lacquer Formulation Optimized by QbD Approach.
Shah VH; Jobanputra A
AAPS PharmSciTech; 2018 Jan; 19(1):213-224. PubMed ID: 28681334
[TBL] [Abstract][Full Text] [Related]
15. Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation.
Elsherif NI; Shamma RN; Abdelbary G
AAPS PharmSciTech; 2017 Feb; 18(2):551-562. PubMed ID: 27138036
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive study to evaluate the effect of constant low voltage iontophoresis on transungual delivery.
Nair AB; Singh K; Shinu P; Harsha S; Al-Dhubiab BE
Drug Dev Ind Pharm; 2013 May; 39(5):807-15. PubMed ID: 23057692
[TBL] [Abstract][Full Text] [Related]
17. Iontophoretic terbinafine HCL 1.0% delivery across porcine and human nails.
Amichai B; Mosckovitz R; Trau H; Sholto O; Ben-Yaakov S; Royz M; Barak D; Nitzan B; Shemer A
Mycopathologia; 2010 May; 169(5):343-9. PubMed ID: 20012894
[TBL] [Abstract][Full Text] [Related]
18. Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis.
Tanrıverdi ST; Özer Ö
Eur J Pharm Sci; 2013 Mar; 48(4-5):628-36. PubMed ID: 23295582
[TBL] [Abstract][Full Text] [Related]
19. Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers.
Khengar RH; Jones SA; Turner RB; Forbes B; Brown MB
Pharm Res; 2007 Dec; 24(12):2207-12. PubMed ID: 17665289
[TBL] [Abstract][Full Text] [Related]
20. Overcoming the nail barrier: A systematic investigation of ungual chemical penetration enhancement.
Brown MB; Khengar RH; Turner RB; Forbes B; Traynor MJ; Evans CR; Jones SA
Int J Pharm; 2009 Mar; 370(1-2):61-7. PubMed ID: 19071202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
